Loading...
Animal Health and Pharmaceuticals, Livestock Feed and Supplements, Food Additives and Ingredients, Feed Additives and Ingredients, Consulting and Professional Services
Antibiotics: Terramycin, Neo-Terramycin
Antimicrobials: Banminth, Mecadox
Vaccines: MJPRRS Vaccine
Phibro Animal Health (Thailand) Limited is the Thai subsidiary of Phibro Animal Health Corporation (PAHC), a globally renowned company specializing in animal health, nutritional products, and vaccines. Operating under the umbrella of the multinational headquartered in Teaneck, New Jersey, USA, Phibro Thailand serves the country’s rapidly growing livestock and poultry sectors with science-driven health solutions and a strong emphasis on responsible animal care.
With a dedicated presence in Bangkok, the company plays a key role in delivering Phibro’s high-quality products, technical services, and innovation to Southeast Asian producers, integrators, and veterinary professionals.
Phibro Animal Health (Thailand) Limited is focused on the marketing, distribution, and technical support of animal health and nutrition products. These include therapeutic antibiotics, antimicrobials, vaccines, and nutritional feed additives that help manage disease, improve productivity, and reduce environmental impact across livestock and poultry farming systems.
The Thai division works in close collaboration with regional and global Phibro R&D and manufacturing teams to ensure product compliance and efficacy under tropical farming conditions.
Phibro Thailand’s product portfolio includes:
Antibiotics and Antimicrobials:
Vaccines:
Nutritional and Functional Additives:
These products are supported with technical services including disease diagnostics, vaccination programs, and customized farm management protocols.
Phibro Thailand’s key differentiators stem from its integration of global research with local expertise:
These strengths make Phibro Thailand a trusted partner in disease prevention and production optimization.
While country-specific financials are not disclosed separately, Phibro Animal Health Corporation (NASDAQ: PAHC) reported the following in its global 2023 annual report:
This growth is attributed to increased demand for PRRS vaccines, gut health solutions, and responsible antimicrobial use programs in swine and poultry.
Trade intelligence and regional logistics reports indicate:
All shipments are managed in compliance with Thai FDA and Ministry of Agriculture regulations.
Phibro Thailand serves a broad professional client base:
Its solutions are targeted at mid-to-large scale operations requiring performance-oriented, regulated products with reliable technical support.
The Thailand division acts as a bridge between Phibro’s global innovation and local farm-level implementation.
Phibro Thailand operates under stringent compliance regimes:
All products are tracked via batch control systems for full traceability.
“Phibro’s MJPRRS vaccine helped us regain productivity after recurrent PRRS outbreaks. Their veterinary support and vaccination protocols are top-notch.”
— Somchai T., Swine Farm Manager, Thailand
“Terramycin remains one of our most reliable tools in respiratory disease management. It’s backed by years of field use and performance.”
— Dr. Narong S., Poultry Consultant, Central Thailand
Phibro Animal Health (Thailand) Limited continues to empower animal producers with data-driven, sustainable, and scientifically validated health solutions—reinforcing its position as a preferred partner for livestock productivity and veterinary excellence in Southeast Asia.
